Abstract: The present invention provides novel drechsleranol compounds of formula (I) which are formed by the microorganism Drechslera australlensis, ST 003360, DSM 14093, or a fungus ST 004112, DSM 14524, during fermentation. A process for their preparation, pharmaceutical compositions containing said drechsleranols their use for the treatment and/or prophylaxis of degenerative neuropathies, such as, Alzheimeu's disease, or psychiatric disorders, such as depression, sleep disturbance or seasonal affective disorder, and their use as chelating agents or antioxidants are also disclosed and claimed.
Abstract: The present invention provides novel processes for the preparation of combretastatins or stilbene compounds of formulae (I) and (III)
wherein A is NH2 or
and PG is a protecting group.
Type:
Grant
Filed:
April 9, 2003
Date of Patent:
July 6, 2004
Assignee:
Aventis Pharma S.A.
Inventors:
Stéphane Mutti, Michel Lavigne, Irina Malejonock, Jean-Paul Casimir
Abstract: The present invention comprises a pseudopolymorph of (−)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4R-(3S-hydroxy-1-methyl)piperidinyl]-4H-1-benzopyran-4-one hydrochloride, a method of making same, a pharmaceutical composition and methods of using the pseudopolymorph.
Type:
Grant
Filed:
January 16, 2001
Date of Patent:
June 10, 2003
Assignee:
Aventis Pharmaceuticals Inc.
Inventors:
Gary L. Bafus, Christine M. Harrison-Bowman, Gary Lee Silvey